September 17, 2022
Becker News writes, “A landmark peer-reviewed study appears to be the first of its kind to provide hard data on the ‘excess risk’ of adverse side effects of Pfizer-BioNTech and Moderna mRNA vaccines in an independent ‘randomized clinical trial’. The study found:
- In the Moderna trial, the excess risk of serious AESIs (15.1 per 10,000 participants) was higher than the risk reduction for COVID-19 hospitalization relative to the placebo group (6.4 per 10,000 participants),”.
- In the Pfizer trial, the excess risk of serious AESIs (10.1 per 10,000) was higher than the risk reduction for COVID-19 hospitalization relative to the placebo group (2.3 per 10,000 participants).
The study was published on ScienceDirect on August 31, 2022. The authors include researchers from Stanford University, the University of Maryland, and UCLA”.
